Healthcare provider profile · identity verified

Omar E Diaz Sojo, M.D.

General Practice · CAROLINA, PR · NPI 1104802065

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	817	161
Metformin Hcl	Metformin Hcl	409	80
Gabapentin	Gabapentin	366	103
Losartan Potassium	Losartan Potassium	362	69
Levothyroxine Sodium	Levothyroxine Sodium	318	55
Lisinopril	Lisinopril	314	51
Pantoprazole Sodium	Pantoprazole Sodium	266	70
Famotidine	Famotidine	259	74
Alendronate Sodium	Alendronate Sodium	255	46
Amlodipine Besylate	Amlodipine Besylate	231	44
Synthroid	Levothyroxine Sodium	214	39
Glipizide	Glipizide	210	39
Metoprolol Succinate	Metoprolol Succinate	199	37
Montelukast Sodium	Montelukast Sodium	199	44
Farxiga	Dapagliflozin Propanediol	190	33
Simvastatin	Simvastatin	186	36
Omeprazole	Omeprazole	180	34
Tamsulosin Hcl	Tamsulosin Hcl	178	31
Hydrochlorothiazide	Hydrochlorothiazide	173	29
Finasteride	Finasteride	171	35
Rosuvastatin Calcium	Rosuvastatin Calcium	169	34
Candesartan Cilexetil	Candesartan Cilexetil	164	29
Clopidogrel	Clopidogrel Bisulfate	136	27
Lantus	Insulin Glargine,hum.Rec.Anlog	122	19
Donepezil Hcl	Donepezil Hcl	105	21
Glyxambi	Empagliflozin/Linagliptin	102	20
Glimepiride	Glimepiride	97	26
Memantine Hcl	Memantine Hcl	92	22
Fenofibrate	Fenofibrate	90	17
Enalapril Maleate	Enalapril Maleate	89	18
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	85	49
Nifedipine Er	Nifedipine	84	16
Furosemide	Furosemide	76	19
Sertraline Hcl	Sertraline Hcl	76	21
Sucralfate	Sucralfate	75	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	12
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	73	12
Atenolol	Atenolol	72	11
Dexamethasone	Dexamethasone	69	52
Bumetanide	Bumetanide	68	21
Levofloxacin	Levofloxacin	68	61
Nabumetone	Nabumetone	68	46
Olanzapine	Olanzapine	67	14
Pentoxifylline	Pentoxifylline	66	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	65	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	62	54
Carvedilol	Carvedilol	61	15
Meclizine Hcl	Meclizine Hcl	60	19
Clonazepam	Clonazepam	58	13
Eliquis	Apixaban	56	13
Meloxicam	Meloxicam	52	37
Methylprednisolone	Methylprednisolone	52	44
Temazepam	Temazepam	50	12
Jentadueto	Linagliptin/Metformin Hcl	49	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	49	suppressed
Azithromycin	Azithromycin	48	43
Memantine Hcl Er	Memantine Hcl	47	suppressed
Ezetimibe	Ezetimibe	46	13
Spironolactone	Spironolactone	44	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	31
Clindamycin Hcl	Clindamycin Hcl	40	35
Diclofenac Potassium	Diclofenac Potassium	38	22
Hydroxyzine Pamoate	Hydroxyzine Pamoate	38	suppressed
Symbicort	Budesonide/Formoterol Fumarate	37	suppressed
Diclofenac Sodium	Diclofenac Sodium	36	19
Fluticasone Propionate	Fluticasone Propionate	36	13
Levetiracetam	Levetiracetam	36	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	31
Humalog	Insulin Lispro	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	34	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	34	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	33	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	32	17
Brilinta	Ticagrelor	32	suppressed
Cilostazol	Cilostazol	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Nitroglycerin	Nitroglycerin	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Tradjenta	Linagliptin	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Risperidone	Risperidone	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	12
Dicyclomine Hcl	Dicyclomine Hcl	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Clobetasol Propionate	Clobetasol Propionate	25	12
Fenofibrate	Fenofibrate,micronized	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Baclofen	Baclofen	24	22
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Celecoxib	Celecoxib	23	15
Chlorthalidone	Chlorthalidone	23	suppressed
Mupirocin	Mupirocin	23	15
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Diltiazem Hcl	Diltiazem Hcl	22	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	22	suppressed
Galantamine Er	Galantamine Hbr	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Rivastigmine	Rivastigmine	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Ondansetron Odt	Ondansetron	19	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Betamethasone Valerate	Betamethasone Valerate	16	11
Entresto	Sacubitril/Valsartan	16	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	16	suppressed
Indapamide	Indapamide	16	suppressed
Prednisone	Prednisone	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Advocate Syringes	Syring-Needl,disp,insul,0.3 Ml	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Estazolam	Estazolam	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Permethrin	Permethrin	13	13
Jardiance	Empagliflozin	12	suppressed
Trazodone Hcl	Trazodone Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Linzess	Linaclotide	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	11	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Tobramycin	Tobramycin	11	suppressed
Xarelto	Rivaroxaban	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error